ConductScience.org, home

Paper40313508

Developing a predictive model for blood-brain-barrier permeability to explore relevance of in vitro neurotoxicity data for in vivo risk assessment.

Illa SE and 3 others. Front Toxicol, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Developing a predictive model for blood-brain-barrier permeability to explore relevance of in vitro neurotoxicity data for in vivo risk assessment. Papers, record 40313508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40313508

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Developing a predictive model for blood-brain-barrier permeability to explore relevance of in vitro neurotoxicity data for in vivo risk assessment.
PubMed
Journal
Front Toxicol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-03-07
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Illa SESiena E
2Feng Earley YYumei
3Li LLi
4Li DDingsheng

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DK135621NIDDK NIH HHSUnited StatesR01DK135621PubMedNIH RePORTER
R01 HL122770NHLBI NIH HHSUnited StatesR01HL122770PubMedNIH RePORTER

Download CSV of grants

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133662518Effective exposure of chemicals in in vitro cell systems: A review of chemical distribution models.Toxicol In Vitro2021https://conductscience.org/library/papers/33662518PubMed
229170977Species differences and mechanism of action of A3 adenosine receptor allosteric modulators.Purinergic Signal2018https://conductscience.org/library/papers/29170977PubMed
320833708The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and man.Toxicol Sci2010https://conductscience.org/library/papers/20833708PubMed
416417033Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data.Crit Rev Toxicol2005https://conductscience.org/library/papers/16417033PubMed
520635475Application of PAMPA-models to predict BBB permeability including efflux ratio, plasma protein binding and physicochemical parameters.Int J Pharm2010https://conductscience.org/library/papers/20635475PubMed
610807556Pulmonary toxicity and carcinogenicity of trichloroethylene: species differences and modes of action.Environ Health Perspect2000https://conductscience.org/library/papers/10807556PubMed
729634986Use of physiologically based kinetic modelling-facilitated reverse dosimetry to convert in vitro cytotoxicity data to predicted in vivo liver toxicity of lasiocarpine and riddelliine in rat.Food Chem Toxicol2018https://conductscience.org/library/papers/29634986PubMed
831532525Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization.Toxicol Sci2020https://conductscience.org/library/papers/31532525PubMed
936691848Cell culture: in vitro model system and a promising path to in vivo applications.J Histotechnol2023https://conductscience.org/library/papers/36691848PubMed
1026344358Tuning the predictive capacity of the PAMPA-BBB model.Eur J Pharm Sci2015https://conductscience.org/library/papers/26344358PubMed
1128872681Development of a direct contact astrocyte-human cerebral microvessel endothelial cells blood-brain barrier coculture model.J Pharm Pharmacol2017https://conductscience.org/library/papers/28872681PubMed
1231356915Profiling 58 compounds including cosmetic-relevant chemicals using ToxRefDB and ToxCast.Food Chem Toxicol2019https://conductscience.org/library/papers/31356915PubMed
1332927283Evaluating consumer exposure to disinfecting chemicals against coronavirus disease 2019 (COVID-19) and associated health risks.Environ Int2020https://conductscience.org/library/papers/32927283PubMed
1421071550Toxic influence of organophosphate, carbamate, and organochlorine pesticides on cellular metabolism of lipids, proteins, and carbohydrates: a systematic review.Hum Exp Toxicol2011https://conductscience.org/library/papers/21071550PubMed
1528470333Extracorporeal perfusion of isolated organs of large animals - Bridging the gap between in vitro and in vivo studies.ALTEX2018https://conductscience.org/library/papers/28470333PubMed
1638108064Development and validation of PAMPA-BBB QSAR model to predict brain penetration potential of novel drug candidates.Front Pharmacol2023https://conductscience.org/library/papers/38108064PubMed
1727016491Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I.Food Chem Toxicol2016https://conductscience.org/library/papers/27016491PubMed
1825542610Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.Eur J Pharm Sci2015https://conductscience.org/library/papers/25542610PubMed
1939033510Discovery Phase Agrochemical Predictive Safety Assessment Using High Content In Vitro Data to Estimate an In Vivo Toxicity Point of Departure.J Agric Food Chem2024https://conductscience.org/library/papers/39033510PubMed
2022667820Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results.Crit Rev Toxicol2012https://conductscience.org/library/papers/22667820PubMed

See all 39 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42909160Static or microfluidic? A comparative pilot study of an in vivo-in vitro validated human iPSC-derived blood-brain barrier model for neurotoxicity hazard assessment.NAM J2026https://conductscience.org/library/papers/42909160PubMed
42038106Towards learning and memory risk assessment with human brain organoids: barriers and opportunities.Front Toxicol2026https://conductscience.org/library/papers/42038106PubMed
41878011In Vitro BBB triculture assay and preliminary computational model development to predict brain exposure.Front Toxicol2026https://conductscience.org/library/papers/41878011PubMed
41270976Informing development of brain cancer therapies within "preclinical trials" using ex vivo patient tumors.Adv Drug Deliv Rev2026https://conductscience.org/library/papers/41270976PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40313508

GET https://conductscience.org/api/papers/v1/40313508/references?page=2